Semaglutide
A GLP-1 receptor agonist that improves glycemic control and reduces appetite.
Written by Anthivera EditorialPending medical review
Updated Regulatory status verified May 1, 2026
FDA-approved
Relevance for women
FDA-approved for weight management (Wegovy) and type 2 diabetes (Ozempic); widely prescribed via telehealth.
Recent research mentioning Semaglutide
Pulled from our weekly editorial digest of PubMed, FDA, NEJM, JAMA, and Endpoints — cite-worthy entries only.
The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-Transporter-2 Inhibitors on Lean Body Mass in Humans: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
PubMed (women's-health + peptide query) · 2026 Jul · digested 2026-06-22
Interpretable machine learning for rare events: an inverse probability weighted application to understanding glucagon-like peptide-1 receptor agonists use and incident alcohol-related disorder.
PubMed (women's-health + peptide query) · 2026 May 13 · digested 2026-06-22
Evidence-informed guidance for the clinical use of oral semaglutide in obesity management.
PubMed (women's-health + peptide query) · 2026 Jun 12 · digested 2026-06-15
Boerhaave's syndrome associated with glucagon-like peptide-1 receptor agonist use: a case report.
PubMed (women's-health + peptide query) · 2026 Jun 12 · digested 2026-06-15
Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study.
PubMed (women's-health + peptide query) · 2026 Jun 7 · digested 2026-06-08
Where the evidence sits
Anthivera’s calibrated five-tier scale — what the strongest evidence on Semaglutide actually supports today.
- Preclinical
- Limited clinical
- Multiple human studies
- Phase 3
- FDA-approvedSemaglutide
FDA-approved: FDA-approved for the indication claimed.
Questions to bring to a consult
- 01What evidence is there for Semaglutide in women specifically — and does that include perimenopausal or postmenopausal cohorts?
- 02What is the current FDA regulatory status, and which compounding pharmacy will my prescription go through?
- 03What baseline labs do you require before starting, and how often do you monitor?
- 04What are the realistic timelines and what does “not working for you” look like in practice?
Providers that offer Semaglutide
- 4.5/5
Evergreen Women's Health
Strongest fit for perimenopausal women seeking continuity of care — pairs hormone testing with peptide protocols.
- 4.0/5
Canopy Telehealth Clinic
Broad catalog and broad geographic reach; longer intake process but thorough lab work.
See the full provider comparison for all peptides side by side.